Details for New Drug Application (NDA): 218070
✉ Email this page to a colleague
The generic ingredient in LIOTHYRONINE SODIUM is liothyronine sodium. There are four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
Summary for 218070
Tradename: | LIOTHYRONINE SODIUM |
Applicant: | Biocon Pharma |
Ingredient: | liothyronine sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 218070
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LIOTHYRONINE SODIUM | liothyronine sodium | TABLET;ORAL | 218070 | ANDA | Biocon Pharma Inc. | 70377-114 | 70377-114-11 | 90 TABLET in 1 BOTTLE (70377-114-11) |
LIOTHYRONINE SODIUM | liothyronine sodium | TABLET;ORAL | 218070 | ANDA | Biocon Pharma Inc. | 70377-114 | 70377-114-12 | 100 TABLET in 1 BOTTLE (70377-114-12) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.005MG BASE | ||||
Approval Date: | Feb 6, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.025MG BASE | ||||
Approval Date: | Feb 6, 2024 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.05MG BASE | ||||
Approval Date: | Feb 6, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription